The objectives of the Columbia University Education and Information Core are to provide training to physicians, facilitate recruitment and retention of research participants, and develop outreach programs to promote ADRC activities. To accomplish this, we will continue designing and implementing seminars, presentations, publications, and CME courses to familiarize clinicians with standard of care and research trends in the diagnosis, treatment, and management of dementia. We will continue the rigorous evaluation of our programs to ensure that they meet the educational objectives and goals. Over the next 5 years, the Education Core will develop a comprehensive education program for physicians-in-training. We have already piloted this program for first-year neurology residents and the program will be expanded into a mini-fellowship to include residents and fellows from other disciplines of medicine. The new cohort to be enrolled by the Clinical Core requires creating an educational program designed to overcome barriers to minority recruitment into clinical research and autopsy programs. This new cohort of community dwelling participants, receiving home care from the Isabella Geriatric Center in Northern Manhattan, are predominantly Hispanic or African American. Culturally sensitive information, presentations and materials will be created to address the attitudes and obstacles to participating in clinical trials and obtaining permission for autopsy. Methods of evaluating the effectiveness of these programs will be developed with the assistance of the Center for Curriculum Evaluation and Faculty Support at Columbia University. The Education Core will continue our service specific activities of providing education to caregivers and the lay public about disease treatment and research opportunities. Another service specific aim is to facilitate recruitment into the genetics initiative by designing educational programs targeted to minorities.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-18
Application #
7431739
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
18
Fiscal Year
2007
Total Cost
$101,209
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Tariciotti, Leonardo; Casadei, Matthew; Honig, Lawrence S et al. (2018) Clinical Experience with Cerebrospinal Fluid A?42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis 65:1417-1425

Showing the most recent 10 out of 640 publications